[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
Francois Brisebois Reiterated (TARS) at Buy with Increased Target to $63 on, Aug 9th, 2024
- 🞛 This publication is a summary or evaluation of another publication
Francois Brisebois of Oppenheimer, Reiterated "Tarsus Pharmaceuticals, Inc." (TARS) at Buy with Increased Target from $61 to $63 on, Aug 9th, 2024.
Francois has made no other calls on TARS in the last 4 months.
There are 2 other peers that have a rating on TARS. Out of the 2 peers that are also analyzing TARS, 0 agree with Francois's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Francois
- Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $61 on, Monday, May 13th, 2024
- Balaji Prasad of "Barclays" Maintained at Buy with Increased Target to $60 on, Friday, May 10th, 2024